重组人促红素致纯红细胞再生障碍性贫血1例被引量：1

下载PDF

导出

摘要病例：患者，男，57岁。2011年5月发现肾功能异常，血肌酐轻度升高，给予保守治疗，定期复查肾功能基本稳定。2012年2月患者出现血肌酐升高，

作者张圣雨田晶晶姜玲王崇薇

机构地区安徽医科大学附属省立医院药剂科淮南市第一人民医院药剂科

出处《中国药物警戒》 2014年第1期59-60,共2页 Chinese Journal of Pharmacovigilance

关键词纯红细胞再生障碍性贫血重组人促红素肾功能异常血肌酐升高保守治疗定期复查患者

参考文献7

1Bergrem H,Danielson B G,Eckardt K U. A case of antierythropoiet in antibodies following recombinant human erythropoietin treatment[A].{H}New York,Marcel,Dekker,Inc,1993.266-275.
2Casadevall N,Nataf J,Viron B. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin[J].{H}New England Journal of Medicine,2002,(7):469-475.
3Storring P L,Tiplady R J,Gaines Das R E. Epoetin alfa and beta differ in their erythropoietin isoform compositions and biological properties[J].{H}British Journal of Haematology,1998,(1):79-89.
4Casadevall N. Pure red cell aplasia and anti-erythropoietin antibodiesin patients treated with epoetin[J].{H}Nephrology Dialysis Transplantation,2003,(8):37-41.
5Gershon S K,Luksenburg H,Coté T R. Pure red-cell aplasia and recombinant erythropoietin[J].{H}New England Journal of Medicine,2002,(20):1584-1592.
6Weber G,Gross J,Kromnfinga A. Allergic skin and systemic reactions in a patient with pure red cell aplasia and anti-erythropoietin antibodies challenged with different epoetins[J].{H}Journal of the American Society of Nephrology,2002,(9):2381-2383.
7陈香美,冯全洲.促红细胞生成素引起纯红细胞再生障碍性贫血[J].药物不良反应杂志,2004,6(2):95-96. 被引量：13

1Bergrem H, Danielson BG, Eckardt KU, et al. A case of antierythropoietin antibodies following recombinant human erythropoietin treatment. In: Erythropoietin: molecular physiology and clinical application [M] . New York: Marcel Dekker, 1993: 266.
2Weber G, Gross J, Kromminga A, et al. Allergic skin and systemic reactions in a patient with pure red cell aplasia and anti-erythropoietin antibodies challenged with different epoetins [J]. J Am Soc Nephrol,2002, 13: 2381.
3Casadevall N. PRCA and antierythropoietin antibodies in patients treated with recombinant erythropoietin [J] .N Engl J Med, 2002, 346: 265.
4Casadevall N, Nataf J, Viron B, et al. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant [J] . Erythropoietin, 2002,346: 469.
5Sasaki H, Bothner B, Dell A, et al. Carbohydrate structure of erythropoietin expressed in Chinese hamster ovary cells by a human erythropoietin cDNA[ J] . J Biol Chen, 1987, 262: 12059.
6Storring PL, Tiplady R J, Gaines Das RE, et al. Epoetin alfa and beta differ in their erythropoietin isoform compositions and biological properties [ J] . Br J Haematol, 1998, 100: 79.
7Besarab A, Reyes CM, Homberger J. Meta-analysis of subcutaneous versus intravenous epoetin in maintenance treatment of anemia in hemodialysis patients [J] . Am J KidneyDis, 2002, 40: 439.
8National Kidney Foundation-K/DOQI. Clinical practice guidelines for the management of anemia of chronic renal failure [J] . Am J Kid Dis, 2001, Suppl5: S182.